Natalie L. Rasgon

Psychiatrist

Professor of Psychiatry and Behavioral Sciences (Psychopharmacology) and, by courtesy, of Obstetrics and Gynecology (Maternal Fetal Medicine) at the Stanford University Medical Center
Dr. Rasgon is a Professor in the Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology in the Stanford School of Medicine. Dr. Rasgon has been involved in longitudinal placebo-controlled neuroendocrine studies for over two decades, and she has been involved in neuroendocrine and brain imaging studies of estrogen effects on depressed menopausal women for over 10 years. In addition to her duties as a Professor of Psychiatry and Obstetrics & Gynecology, Dr. Rasgon is also the Director of the Stanford Center for Neuroscience in Women’s Health and Associate Dean of Academic Affairs for the School of Medicine. She has an extensive history of teaching and mentoring, and many of her trainees have secured independent faculty positions in academia.

Outpatient Psychiatry Clinic

  • 401 Quarry Road
  • Stanford, CA 94304
  • Phone: 650-498-9111
Learn More About the Clinic » Getting Here » Make An Appointment

Professional Education

Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1998)

Fellowship: UCLA Medical Center (1996) CA

Residency: Cedars-Sinai Medical Center (1995) CA

Internship: Harbor-UCLA Medical Center (1993) CA

Medical Education: Odessa Medical Institute (1980) Russia

PhD, Academy of Medical Sciences, Pathological Physiology (1988)

PhD, Academy of Medical Sciences, Obstetrics & Gynecology (1988)

MD, Odessa Medical Institute, Diploma with Highest Honors (1980)

Honors & Awards

Fellowship, Stanford Clayman Institute for Gender Research (2011)

Elected to Database, Best Doctors in America (November 2012)

Lila A. Wallis Award, American Medical Women’s Association (2010)

International Scientist of the Year, International Biographical Centre of Cambridge, England (2002)

Leo G. Rigler, M.D. Award for Academic Achievement, Cedars-Sinai Medical Center (1995)

Diploma with Highest Honors, Odessa Medical Institute (1980)

First Prize, Student Research Work, Soviet Union Scientific Student Competition (1978)

Administrative Appointments

Associate Dean, Office of Academic Affairs (2012 - 2013)

Director, Stanford Center for Neuroscience in Women's Health (2002 - Present)

Member, Appointments and promotions committee SOM (2009 - 2012)

Director, Stanford Women’s Health Component, Ph.D. Program, Pacific Graduate School of Psychology (2009 - Present)

Director, Faculty Mentoring Program, Department of Psychiatry, Stanford University (2009 - Present)

Director, Center for Neuroscience in Women’s Health, Stanford University (2007 - Present)

Chair of the SOM Senate, Stanford School of Medicine (2009 - 2012)

Administrative Panel on Human Subjects in Medical Research, Stanford University (2004 - 2009)

Advisory Board on Women’s Health, Stanford Unviversity (2004 - Present)

Member, Scholar Universe Neuroscience (2004 - Present)

Alternate Senator, Stanford School of Medicine (2004 - 2006)

Co-Chair, Faculty Women’s Forum, Stanford University (2004 - Present)

Women's Cardiovascular Health Committee, Stanford Cardiovascular Institute (2004 - Present)

Medical School Admissions Panel, Stanford University (2003 - 2005)

Chair, Women’s Wellness Seminars Program, Stanford University (2003 - Present)

Chair, Search Committee for the Elizabeth Blackwell Award, UCLA School of Medicine (1999 - 2003)

Search Committee for the Norman Cousins Psychoneuroimmunology Chair, UCLA School of Medicine (1998 - 1998)

UCLA Liver Transplant Committee, UCLA School of Medicine (1997 - 2002)

International Medical Graduates Committee, Southern California Psychiatric Society (1993 - 2001)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Relationship between sunlight and the age of onset of bipolar disorder: An international multisite study.
Bauer, M., Glenn, T., Alda, M., Andreassen, O. A., Angelopoulos, E., & Whybrow, P. C. (2014). Relationship between sunlight and the age of onset of bipolar disorder: An international multisite study. Journal of affective disorders, 167, 104-111.

Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy
Rasgon, N. L., Kenna, H. A., Wroolie, T. E., Williams, K. E., DeMuth, B. N., & Silverman, D. Hs. (2014). Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy. PSYCHIATRY RESEARCH-NEUROIMAGING, 223(1), 28-36.

Prospective Randomized Trial to Assess Effects of Continuing Hormone Therapy on Cerebral Function in Postmenopausal Women at Risk for Dementia
Rasgon, N. L., Geist, C. L., Kenna, H. A., Wroolie, T. E., Williams, K. E., & Silverman, D. Hs. (2014). Prospective Randomized Trial to Assess Effects of Continuing Hormone Therapy on Cerebral Function in Postmenopausal Women at Risk for Dementia. PLOS ONE, 9(3).

Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women
Kenna, H. A., Reynolds-May, M., Stepanenko, A., Ketter, T. A., Hallmayer, J., & Rasgon, N. L. (2014). Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women. JOURNAL OF AFFECTIVE DISORDERS, 156, 214-218.

Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls
Reynolds-May, M. F., Kenna, H. A., Marsh, W., Stemmle, P. G., Wang, P., & Rasgon, N. L. (2014). Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls. BIPOLAR DISORDERS, 16(1), 37-47.

Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia.
Rasgon, N. L., Geist, C. L., Kenna, H. A., Wroolie, T. E., Williams, K. E., & Silverman, D. Hs. (2014). Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. PloS one, 9(3).

High Rates of Comorbid Depressive and Anxiety Disorders Among Women with Premutation of the FMR1 Gene
Kenna, H. A., Tartter, M., Hall, S. S., Lightbody, A. A., Quynh Nguyen, Q., & Rasgon, N. L. (2013). High Rates of Comorbid Depressive and Anxiety Disorders Among Women with Premutation of the FMR1 Gene. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 162(8), 872-878.

High rates of comorbid depressive and anxiety disorders among women with premutation of the FMR1 gene.
Kenna, H. A., Tartter, M., Hall, S. S., Lightbody, A. A., Nguyen, Q., & Rasgon, N. L. (2013). High rates of comorbid depressive and anxiety disorders among women with premutation of the FMR1 gene. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 162(8), 872-878.

Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease
Kenna, H., Hoeft, F., Kelley, R., Wroolie, T., Demuth, B., & Rasgon, N. (2013). Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease. NEUROBIOLOGY OF AGING, 34(3), 641-649.

Accelerated Cell Aging in Female APOE-epsilon 4 Carriers: Implications for Hormone Therapy Use
Jacobs, E. G., Kroenke, C., Lin, J., Epel, E. S., Kenna, H. A., & Rasgon, N. L. (2013). Accelerated Cell Aging in Female APOE-epsilon 4 Carriers: Implications for Hormone Therapy Use. PLOS ONE, 8(2).

Enhanced Ziprasidone Combination Therapy Effectiveness in Obese Compared to Nonobese Patients With Bipolar Disorder
Miller, S., Ittasakul, P., Wang, P. W., Hill, S. J., Childers, M. E., & Ketter, T. A. (2012). Enhanced Ziprasidone Combination Therapy Effectiveness in Obese Compared to Nonobese Patients With Bipolar Disorder. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 32(6), 814-819.

Impact of sunlight on the age of onset of bipolar disorder
Bauer, M., Glenn, T., Alda, M., Andreassen, O. A., Ardau, R., & Whybrow, P. C. (2012). Impact of sunlight on the age of onset of bipolar disorder. BIPOLAR DISORDERS, 14(6), 654-663.

Enhanced zipirasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder
Rasgon, N. (2012). Enhanced zipirasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder. J Clin Psychopharmacol, Dec.

Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease
Rasgon, N. L., Kenna, H. A., Wroolie, T. E., Kelley, R., Silverman, D., & Reiss, A. (2011). Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. NEUROBIOLOGY OF AGING, 32(11), 1942-1948.

Differences in Verbal Memory Performance in Postmenopausal Women Receiving Hormone Therapy: 17 beta-Estradiol Versus Conjugated Equine Estrogens
Wroolie, T. E., Kenna, H. A., Williams, K. E., Powers, B. N., Holcomb, M., & Rasgon, N. L. (2011). Differences in Verbal Memory Performance in Postmenopausal Women Receiving Hormone Therapy: 17 beta-Estradiol Versus Conjugated Equine Estrogens. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 19(9), 792-802.

Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients
Wang, P. W., Hill, S. J., Childers, M. E., Chandler, R. A., Rasgon, N. L., & Ketter, T. A. (2011). Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients. JOURNAL OF PSYCHIATRIC RESEARCH, 45(8), 1128-1132.

Decreasing the minimum length criterion for an episode of hypomania: evaluation using self-reported data from patients with bipolar disorder
Bauer, M., Glenn, T., Rasgon, N., Marsh, W., Sagduyu, K., & Whybrow, P. C. (2011). Decreasing the minimum length criterion for an episode of hypomania: evaluation using self-reported data from patients with bipolar disorder. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 261(5), 341-347.

Gender-specific lipid profiles in patients with bipolar disorder
Vemuri, M., Kenna, H. A., Wang, P. W., Ketter, T. A., & Rasgon, N. L. (2011). Gender-specific lipid profiles in patients with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 45(8), 1036-1041.

Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD
Silverman, D. Hs., Geist, C. L., Kenna, H. A., Williams, K., Wroolie, T., & Rasgon, N. L. (2011). Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD. PSYCHONEUROENDOCRINOLOGY, 36(4), 502-513.

Mood disorders in oocyte donor candidates: brief report and implications for future research
Williams, K. E., Stemmle, P. G., Westphal, L. M., & Rasgon, N. L. (2011). Mood disorders in oocyte donor candidates: brief report and implications for future research. HUMAN REPRODUCTION, 26(4), 847-852.

Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline
Lin, J., Kroenke, C. H., Epel, E., Kenna, H. A., Wolkowitz, O. M., & Rasgon, N. L. (2011). Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline. BRAIN RESEARCH, 1379, 224-231.

Association between median family income and self-reported mood symptoms in bipolar disorder
Bauer, M., Glenn, T., Rasgon, N., Marsh, W., Sagduyu, K., & Whybrow, P. C. (2011). Association between median family income and self-reported mood symptoms in bipolar disorder. COMPREHENSIVE PSYCHIATRY, 52(1), 17-25.

Association between age of onset and mood in bipolar disorder: Comparison of subgroups identified by cluster analysis and clinical observation
Bauer, M., Glenn, T., Rasgon, N., Marsh, W., Sagduyu, K., & Whybrow, P. C. (2010). Association between age of onset and mood in bipolar disorder: Comparison of subgroups identified by cluster analysis and clinical observation. JOURNAL OF PSYCHIATRIC RESEARCH, 44(16), 1170-1175.

Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus
Rasgon, N. L., Kenna, H. A., Reynolds-May, M. F., Stemmle, P. G., Vemuri, M., & Ketter, T. A. (2010). Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus. BIPOLAR DISORDERS, 12(5), 504-513.

Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women
Morgan, M. L., Rapkin, A. J., Biggio, G., Serra, M., Pisu, M. G., & Rasgon, N. (2010). Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. ARCHIVES OF WOMENS MENTAL HEALTH, 13(1), 91-98.

Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: Points of pathophysiological commonality with mood disorders?
McIntyre, R. S., Kenna, H. A., Nguyen, H. T., Law, C. Wy., Sultan, F., & Rasgon, N. L. (2010). Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: Points of pathophysiological commonality with mood disorders?. ADVANCES IN THERAPY, 27(2), 63-80.

Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: Effects of levothyroxine
Bauer, M., Berman, S. M., Schlagenhauf, F., Voytek, B., Rasgon, N., & London, E. D. (2010). Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: Effects of levothyroxine. PSYCHIATRY RESEARCH-NEUROIMAGING, 181(1), 71-76.

Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study
Rasgon, N. L., Kenna, H. A., Williams, K. E., Powers, B., Wroolie, T., & Schatzberg, A. F. (2010). Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study. THESCIENTIFICWORLDJOURNAL, 10, 321-328.

Genetic overlap between polycystic ovary syndrome and bipolar disorder: The endophenotype hypothesis
Jiang, B., Kenna, H. A., & Rasgon, N. L. (2009). Genetic overlap between polycystic ovary syndrome and bipolar disorder: The endophenotype hypothesis. MEDICAL HYPOTHESES, 73(6), 996-1004.

Brain Glucose Metabolism in Hypothyroidism: A Positron Emission Tomography Study before and after Thyroid Hormone Replacement Therapy
Bauer, M., Silverman, D. Hs., Schlagenhauf, F., London, E. D., Geist, C. L., & Whybrow, P. C. (2009). Brain Glucose Metabolism in Hypothyroidism: A Positron Emission Tomography Study before and after Thyroid Hormone Replacement Therapy. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 94(8), 2922-2929.

Comparison of sleep/wake parameters for self-monitoring bipolar disorder
Bauer, M., Glenn, T., Grof, P., Rasgon, N., Alda, M., & Whybrow, P. C. (2009). Comparison of sleep/wake parameters for self-monitoring bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 116(3), 170-175.

Frequency of subsyndromal symptoms and employment status in patients with bipolar disorder
Bauer, M., Glenn, T., Grof, P., Rasgon, N. L., Marsh, W., & Whybrow, P. C. (2009). Frequency of subsyndromal symptoms and employment status in patients with bipolar disorder. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 44(7), 515-522.

Relationship among latitude, climate, season and self-reported mood in bipolar disorder
Bauer, M., Glenn, T., Grof, P., Rasgon, N. L., Marsh, W., & Whybrow, P. C. (2009). Relationship among latitude, climate, season and self-reported mood in bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 116(1-2), 152-157.

Employment status and subsyndromal symptoms in bipolar disorder
Glenn, T., Bauer, M., Grof, P., Rasgon, N. L., Marsh, W., & Whybrow, P. C. (2009). Employment status and subsyndromal symptoms in bipolar disorder. BIPOLAR DISORDERS, 11, 43-43.

Latitude, climate, season and self-reported mood in bipolar disorder
Bauer, M., Glenn, T., Grof, P., Rasgon, N. L., Marsh, W., & Whybrow, P. C. (2009). Latitude, climate, season and self-reported mood in bipolar disorder. BIPOLAR DISORDERS, 11, 19-19.

Increased depressive symptoms in menopausal age women with bipolar disorder: Age and gender comparison
Marsh, W. K., Ketter, T. A., & Rasgon, N. L. (2009). Increased depressive symptoms in menopausal age women with bipolar disorder: Age and gender comparison. JOURNAL OF PSYCHIATRIC RESEARCH, 43(8), 798-802.

Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study
Wroolie, T. E., Kenna, H. A., Williams, K. E., Powers, B. N., Holcomb, M., & Rasgon, N. L. (2009). Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study. ACTA NEUROLOGICA SCANDINAVICA, 119(3), 172-179.

Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap
McIntyre, R. S., Rasgon, N. L., Kemp, D. E., Nguyen, H. T., Law, C. Wy., & Goldstein, B. I. (2009). Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap. CURRENT DIABETES REPORTS, 9(1), 51-59.

Thalamo-Basal Ganglia Connectivity in Postmenopausal Women Receiving Estrogen Therapy
Kenna, H. A., Rasgon, N. L., Geist, C., Small, G., & Silverman, D. (2009). Thalamo-Basal Ganglia Connectivity in Postmenopausal Women Receiving Estrogen Therapy. NEUROCHEMICAL RESEARCH, 34(2), 234-237.

Reproductive and Metabolic Abnormalities Associated with Bipolar Disorder and Its Treatment
Kenna, H. A., Jiang, B., & Rasgon, N. L. (2009). Reproductive and Metabolic Abnormalities Associated with Bipolar Disorder and Its Treatment. HARVARD REVIEW OF PSYCHIATRY, 17(2), 138-146.

Insulin resistance and hyperlipidemia in women with bipolar disorder.
Stemmle, P. G., Kenna, H. A., Wang, P. W., Hill, S. J., Ketter, T. A., & Rasgon, N. L. (2009). Insulin resistance and hyperlipidemia in women with bipolar disorder. Journal of psychiatric research, 43(3), 341-343.

Relationship between adjunctive medications for anxiety and time spent ill in patients with bipolar disorder
Bauer, M., Glenn, T., Grof, P., Rasgon, N. L., Marsh, W., & Whybrow, P. C. (2009). Relationship between adjunctive medications for anxiety and time spent ill in patients with bipolar disorder. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 13(1), 70-77.

Cerebral metabolic patterns in untreated postmenopausal women with major depressive disorder
Rasgon, N. L., Kenna, H. A., Geist, C., Small, G., & Silverman, D. (2008). Cerebral metabolic patterns in untreated postmenopausal women with major depressive disorder. PSYCHIATRY RESEARCH-NEUROIMAGING, 164(1), 77-80.

Changes in self-reported sleep duration predict mood changes in bipolar disorder
Bauer, M., Glenn, T., Whybrow, P. C., Grof, P., Rasgon, N., & Adli, M. (2008). Changes in self-reported sleep duration predict mood changes in bipolar disorder. PSYCHOLOGICAL MEDICINE, 38(7), 1069-1071.

Self-reporting software for bipolar disorder: Validation of ChronoRecord by patients with mania
Bauer, M., Wilson, T., Neuhaus, K., Sasse, J., Pfennig, A., & Whybrow, P. C. (2008). Self-reporting software for bipolar disorder: Validation of ChronoRecord by patients with mania. PSYCHIATRY RESEARCH, 159(3), 359-366.

Regional cerebral metabolism and neuropsychological performance among healthy postmenopausal users of estrogen therapy
Rasgon, N., Kenna, H., Geist, C., Powers, B., Wroolie, T., & Silverman, D. (2008). Regional cerebral metabolism and neuropsychological performance among healthy postmenopausal users of estrogen therapy. BIOLOGICAL PSYCHIATRY, 63(7), 16S-16S.

Insulin resistance and hyperlipidemia in women with bipolar disorder
Rasgon, N. L., Stemmle, P. G., Kenna, H. A., Wong, P. W., Hill, S. J., & Ketter, T. A. (2008). Insulin resistance and hyperlipidemia in women with bipolar disorder. EUROPEAN PSYCHIATRY, 23, S235-S235.

Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary report
Marsh, W. K., Templeton, A., Ketter, T. A., & Rasgon, N. L. (2008). Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary report. JOURNAL OF PSYCHIATRIC RESEARCH, 42(3), 247-251.

Children of persons with Alzheimer disease - What does the future hold?
Jarvik, L., LaRue, A., Blacker, D., Gatz, M., Kawas, C., & Zonderman, A. B. (2008). Children of persons with Alzheimer disease - What does the future hold?. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 22(1), 6-20.

A case of olanzapine-induced gestational diabetes mellitus in the absence of weight gain
Vemuri, M. P., & Rasgon, N. L. (2007). A case of olanzapine-induced gestational diabetes mellitus in the absence of weight gain. JOURNAL OF CLINICAL PSYCHIATRY, 68(12), 1989-1989.

Mood disorders and fertility in women: a critical review of the literature and implications for future research
Williams, K. E., Marsh, W. K., & Rasgon, N. L. (2007). Mood disorders and fertility in women: a critical review of the literature and implications for future research. HUMAN REPRODUCTION UPDATE, 13(6), 607-616.

Self-reported data from patients with bipolar disorder: Frequency of brief depression
Bauer, M., Glenn, T., Grof, P., Pfennig, A., Rasgon, N. L., & Whybrow, P. C. (2007). Self-reported data from patients with bipolar disorder: Frequency of brief depression. JOURNAL OF AFFECTIVE DISORDERS, 101(1-3), 227-233.

Self-reported depression and minimum length of depression episodes in bipolar disorder
Bauer, M., Grof, P., Glenn, T., Rasgon, N. L., Sasse, J., & Whybrow, P. C. (2007). Self-reported depression and minimum length of depression episodes in bipolar disorder. BIPOLAR DISORDERS, 9, 19-19.

Approximate entropy of self-reported mood prior to episodes in patients with bipolar disorder
Glenn, T., Whybrow, P. C., Rasgon, N. L., Grof, P., Alda, M., & Bauer, M. (2007). Approximate entropy of self-reported mood prior to episodes in patients with bipolar disorder. BIPOLAR DISORDERS, 9, 45-45.

Verbal memory retrieval deficits associated with untreated hypothyroidism
Miller, K. J., Parsons, T. D., Whybrow, P. C., Van Herle, K., Rasgon, N., & Bauer, M. (2007). Verbal memory retrieval deficits associated with untreated hypothyroidism. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 19(2), 132-136.

Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study
Rasgon, N. L., Dunkin, J., Fairbanks, L., Altshuler, L. L., Troung, C., & Rapkin, A. (2007). Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study. JOURNAL OF PSYCHIATRIC RESEARCH, 41(3-4), 338-343.

Hypothalamic-pituitary-end organ function in women with bipolar depression
Rasgon, N. L., Kenna, H. A., Wong, M.-L., Whybrow, P. C., & Bauer, M. (2007). Hypothalamic-pituitary-end organ function in women with bipolar depression. PSYCHONEUROENDOCRINOLOGY, 32(3), 279-286.

Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: A review
Reynolds, M. F., Sisk, E. C., & Rasgon, N. L. (2007). Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: A review. CURRENT MEDICINAL CHEMISTRY, 14(26), 2799-2812.

Self-reported data from patients with bipolar disorder: Impact on minimum episode length for hypomania
Bauer, M., Grof, P., Rasgon, N. L., Marsh, W., Munoz, R. A., & Whybrow, P. C. (2006). Self-reported data from patients with bipolar disorder: Impact on minimum episode length for hypomania. JOURNAL OF AFFECTIVE DISORDERS, 96(1-2), 101-105.

Approximate entropy of self-reported mood prior to episodes in bipolar disorder
Glenn, T., Whybrow, P. C., Rasgon, N., Grof, P., Alda, M., & Bauer, M. (2006). Approximate entropy of self-reported mood prior to episodes in bipolar disorder. BIPOLAR DISORDERS, 8(5), 424-429.

Mood and neuropsychological changes in women with midlife depression treated with escitalopram
Wroolie, T. E., Williams, K. E., Keller, J., Zappert, L. N., Shelton, S. D., & Rasgon, N. L. (2006). Mood and neuropsychological changes in women with midlife depression treated with escitalopram. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 26(4), 361-366.

Improving symptom monitoring - using technology to explore the course of bipolar disorder
Glenn, T., Bauer, M., Grof, P., Rasgon, N., & Whybrow, P. C. (2006). Improving symptom monitoring - using technology to explore the course of bipolar disorder. BIPOLAR DISORDERS, 8, 13-13.

Memory improvement with treatment of hypothyroidism
Miller, K. J., Parsons, T. D., Whybrow, P. C., Van Herle, K., Rasgon, N., & Bauer, M. (2006). Memory improvement with treatment of hypothyroidism. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 116(8), 895-906.

Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder
Bauer, M., Rasgon, N., Grof, P., Glenn, T., Lapp, M., & Whybrow, P. C. (2006). Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder. EUROPEAN PSYCHIATRY, 21(4), 262-269.

Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal interaction in women with bipolar depression
Kenna, H. A., Rasgon, N. L., Wong, M. L., & Bauer, M. (2006). Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal interaction in women with bipolar depression. BIOLOGICAL PSYCHIATRY, 59(8), 157S-157S.

Temporal relation between sleep and mood in patients with bipolar disorder
Bauer, M., Grof, P., Rasgon, N., Bschor, T., Glenn, T., & Whybrow, P. C. (2006). Temporal relation between sleep and mood in patients with bipolar disorder. BIPOLAR DISORDERS, 8(2), 160-167.

Cannon-Spoor et al.'s assessment
Rasgon, N., & Jarvik, L. (2006). Cannon-Spoor et al.'s assessment. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 14(3), 293-293.

Estrogen replacement and cognition in postmenopausal women: Effects of years since menopause on response to treatment.
Dunkin J, Rasgon N, Zeller M, Wagner-Steh K, David S, & Rapkin A. (2006). Estrogen replacement and cognition in postmenopausal women: Effects of years since menopause on response to treatment. Drug Development Research, 66.

Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder.
Bauer M, Rasgon N, Grof P, Glenn T, Marsh W, & Whybrow P. (2006). Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder. European Psychiatry, 21.

Hepatic encephalopathy: A neurochemical, neuroanatomical, and neuropsychological study
Binesh, N., Huda, A., Thomas, M. A., Wyckoff, N., Bugbee, M., & Fawzy, F. (2006). Hepatic encephalopathy: A neurochemical, neuroanatomical, and neuropsychological study. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 7(1), 86-96.

Changes in regional brain metabolism and insulin resistance in postmenopausal women.
Rasgon NL, Geist CL, Phelps ME, & Silverman DHS. (2006). Changes in regional brain metabolism and insulin resistance in postmenopausal women. Journal of Nuclear Medicine, 47(S1).

Middle-aged children of Alzheimer parents, a pilot study: Stable neurocognitive performance at 20-year follow-up
Jarvik, L. F., La Rue, A., Gokhman, I., Harrison, T., Holt, L., & Schaeffer, J. (2005). Middle-aged children of Alzheimer parents, a pilot study: Stable neurocognitive performance at 20-year follow-up. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 18(4), 187-191.

Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis.
Rasgon, N. L., & Kenna, H. A. (2005). Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis. Neurobiology of aging, 26, 103-107.

Longitudinal evaluation of reproductive function in women treated for bipolar disorder
Rasgon, N. L., Reynolds, M. F., Elman, S., Saad, M., Frye, M. A., & Altshuler, L. L. (2005). Longitudinal evaluation of reproductive function in women treated for bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 89(1-3), 217-225.

Use of polypharmacy and self-reported mood in outpatients with bipolar disorder
Adli, M., Whybrow, P. C., Grof, P., Rasgon, N., Gyulai, L., & Bauer, M. (2005). Use of polypharmacy and self-reported mood in outpatients with bipolar disorder. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 9(4), 251-256.

Insulin resistance in depressive disorders and Alzheimer's disease: Revisiting the missing link hypothesis
Rasgon, N. L., & Kenna, H. A. (2005). Insulin resistance in depressive disorders and Alzheimer's disease: Revisiting the missing link hypothesis. NEUROBIOLOGY OF AGING, 26, S103-S107.

Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.
Masand, P. S., Culpepper, L., Henderson, D., Lee, S., Littrell, K., & Rasgon, N. (2005). Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization. CNS spectrums, 10(10), 14 1-15.

Estrogen replacement and cognition in postmenopausal women: Effect of years since menopause on response to treatment
Dunkin, J., Rasgon, N., Zeller, M., Wagner-Steh, K., David, S., & Rapkin, A. (2005). Estrogen replacement and cognition in postmenopausal women: Effect of years since menopause on response to treatment. DRUG DEVELOPMENT RESEARCH, 66(2), 150-159.

Vitamin E for the treatment of dysmenorrhea
Rasgon, N. L., & Yarygin, K. N. (2005). Vitamin E for the treatment of dysmenorrhea. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 112(8), 1164-1164.

Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: a preliminary study
Rasgon, N. L., Magnusson, C., Johansson, A. Lv., Pedersen, N. L., Elman, S., & Gatz, M. (2005). Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: a preliminary study. PSYCHONEUROENDOCRINOLOGY, 30(6), 558-567.

Perimenopausal mental disorders: Epidemiology and phenomenology
Rasgon, N., Shelton, S., & Halbreich, U. (2005). Perimenopausal mental disorders: Epidemiology and phenomenology. CNS SPECTRUMS, 10(6), 471-478.

Temporal relation between sleep and mood in patients with bipolar disorder
Bauer, M., Grof, P., Rasgon, N., Bschor, T., Glenn, T., & Whybrow, P. C. (2005). Temporal relation between sleep and mood in patients with bipolar disorder. BIPOLAR DISORDERS, 7, 31-32.

Clinical course of bipolar disorder during pregnancy in women receiving minimal or no prescription psychotropic medication
Marsh, W. K., Zappert, L. N., Williams, E. K., Templeton, A. J., Reynolds, M. F., & Rasgon, N. L. (2005). Clinical course of bipolar disorder during pregnancy in women receiving minimal or no prescription psychotropic medication. BIPOLAR DISORDERS, 7, 75-76.

Validation study of chrono record self-reporting software by inpatients with mania
Bauer, M., Neuhaus, K., Sasse, J., Schlosser, T., Bschor, T., & Whybrow, P. C. (2005). Validation study of chrono record self-reporting software by inpatients with mania. BIPOLAR DISORDERS, 7, 32-32.

Effects of gender on mood in the clinical course of bipolar disorder
Zappert, L. N., Glenn, T. G., Bauer, M., Elman, S., Frye, M., & Rasgon, N. L. (2005). Effects of gender on mood in the clinical course of bipolar disorder. BIPOLAR DISORDERS, 7, 115-115.

Prospective longitudinal study of women treated for bipolar disorder
Reynolds, M. F., Rasgon, N. L., Elman, S., Saad, M., Frye, M. A., & Altshuler, L. L. (2005). Prospective longitudinal study of women treated for bipolar disorder. BIPOLAR DISORDERS, 7, 90-90.

Reproductive function and risk for PCOS in women treated for bipolar disorder
Rasgon, N. L., Altshuler, L. L., Fairbanks, L., Elman, S., Bitran, J., & Mintz, J. (2005). Reproductive function and risk for PCOS in women treated for bipolar disorder. BIPOLAR DISORDERS, 7(3), 246-259.

Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression
Bauer, M., London, E. D., Rasgon, N., Berman, S. M., Frye, M. A., & Whybrow, P. C. (2005). Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. MOLECULAR PSYCHIATRY, 10(5), 456-469.

Reproduction events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women
Dunkin, J., Rasgon, N., Wagner-Steh, K., David, S., Altshuler, L., & Rapkin, A. (2005). Reproduction events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. PSYCHONEUROENDOCRINOLOGY, 30(3), 284-296.

Adding another spectral dimension to H-1 magnetic resonance spectroscopy of hepatic encephalopathy
Binesh, N., Huda, A., Bugbee, M., Gupta, R., Rasgon, N., & Thomas, M. A. (2005). Adding another spectral dimension to H-1 magnetic resonance spectroscopy of hepatic encephalopathy. JOURNAL OF MAGNETIC RESONANCE IMAGING, 21(4), 398-405.

Estrogen use and brain metabolic change in postmenopausal women
Rasgon, N. L., Silverman, D., Siddarth, P., Miller, K., Ercoli, L. M., & Small, G. W. (2005). Estrogen use and brain metabolic change in postmenopausal women. NEUROBIOLOGY OF AGING, 26(2), 229-235.

Mood changes related to antidepressants: a longitudinal study of patients with bipolar disorder in a naturalistic setting
Bauer, M., Rasgon, N., Grof, P., Altshuler, L., Gyulai, L., & Whybrow, P. C. (2005). Mood changes related to antidepressants: a longitudinal study of patients with bipolar disorder in a naturalistic setting. PSYCHIATRY RESEARCH, 133(1), 73-80.

Does the use of an automated tool for self-reporting mood by patients with bipolar disorder bias the collected data?
Bauer, M., Rasgon, N., Grof, P., Gyulai, L., Glenn, T., & Whybrow, P. C. (2005). Does the use of an automated tool for self-reporting mood by patients with bipolar disorder bias the collected data?. MedGenMed : Medscape general medicine, 7(3), 21-?.

Sex-specific self-reported mood changes by patients with bipolar disorder
Rasgon, N., Bauer, M., Grof, P., Gyulai, L., Elman, S., & Whybrow, P. C. (2005). Sex-specific self-reported mood changes by patients with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 39(1), 77-83.

Gender Differences in Bipolar Disorder
Templeton A, & Rasgon N. (2005). Gender Differences in Bipolar Disorder. Bipolar Case Review Quarterly, 1.

Use of polypharmacy and self-report mood in outpatients with bipolar disorder.
Adli M, Whybrow PC, Grof P, Rasgon N, Gyulai L, & Bauer M. (2005). Use of polypharmacy and self-report mood in outpatients with bipolar disorder. International Journal of Psychiatry in Clinical Practice., 9(4).

Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study
Bauer, M., Fairbanks, L., Berghofer, A., HIERHOLZER, J., Bschor, T., & Whybrow, P. C. (2004). Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study. JOURNAL OF AFFECTIVE DISORDERS, 83(2-3), 183-190.

Children of Alzheimer patients: More data needed
Jarvik, L. F., Harrison, T. R., Holt, L., Jimenez, E., Larson, S. W., & Yaralian, P. (2004). Children of Alzheimer patients: More data needed. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 59(10), 1076-1077.

Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report
Becker, O. V., Rasgon, N. L., Marsh, W. K., Glenn, T., & Ketter, T. A. (2004). Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report. BIPOLAR DISORDERS, 6(5), 435-439.

The impact of depression and fluoxetine treatment on obstetrical outcome.
Suri, R., Altshuler, L., Hendrick, V., Rasgon, N., Lee, E., & Mintz, J. (2004). The impact of depression and fluoxetine treatment on obstetrical outcome. Archives of women's mental health, 7(3), 193-200.

The relationship between polycystic ovary syndrome and antiepileptic drugs - A review of the evidence
Rasgon, N. (2004). The relationship between polycystic ovary syndrome and antiepileptic drugs - A review of the evidence. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 24(3), 322-334.

Special considerations in treating bipolar disorder in women
Burt, V. K., & Rasgon, N. (2004). Special considerations in treating bipolar disorder in women. BIPOLAR DISORDERS, 6(1), 2-13.

Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder
Bauer, M., Grof, P., Gyulai, L., Rasgon, N., Glenn, T., & Whybrow, P. C. (2004). Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder. BIPOLAR DISORDERS, 6(1), 67-74.

Insulin resistance, affective disorders, and Alzheimer's disease: Review and hypothesis
Rasgon, N., & Jarvik, L. (2004). Insulin resistance, affective disorders, and Alzheimer's disease: Review and hypothesis. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 59(2), 178-183.

Using software to improve longitudinal studies: self-reporting with chronorecord in bipolar disorder
Trendelenburg, M., Sasse, J., Schlosser, I., Whybrow, P. C., Grof, P., & Bauer, M. (2004). Using software to improve longitudinal studies: self-reporting with chronorecord in bipolar disorder. ACTA PSYCHIATRICA SCANDINAVICA, 110, 39-40.

The electronic assessment of the longitudinal course of bipolar disorder: The ChronoRecord software
Whybrow, P. C., Grof, P., Gyulai, L., Rasgon, N., Glenn, T., & Bauer, M. (2003). The electronic assessment of the longitudinal course of bipolar disorder: The ChronoRecord software. PHARMACOPSYCHIATRY, 36, S244-S249.

Thyroid, brain and mood modulation in affective disorder: Insights from molecular research and functional brain imaging
Bauer, M., London, E. D., Silverman, D. Hs., Rasgon, N., Kirchheiner, J., & Whybrow, P. C. (2003). Thyroid, brain and mood modulation in affective disorder: Insights from molecular research and functional brain imaging. PHARMACOPSYCHIATRY, 36, S215-S221.

Emergent oscillations in mathematical model of the human menstrual cycle
Rasgon, N. L., Pumphrey, L., Prolo, P., Elman, S., Negrao, A. B., & Garfinkel, A. (2003). Emergent oscillations in mathematical model of the human menstrual cycle. CNS SPECTRUMS, 8(11), 805-814.

Depression in women with polycystic ovary syndrome: clinical and biochemical correlates
Rasgon, N. L., Rao, R. C., Hwang, S., Altshuler, L. L., Elman, S., & KORENMAN, S. G. (2003). Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. JOURNAL OF AFFECTIVE DISORDERS, 74(3), 299-304.

Menstrual cycle related mood changes in women with bipolar disorder
Rasgon, N., Bauer, M., Glenn, T., Elman, S., & Whybrow, P. C. (2003). Menstrual cycle related mood changes in women with bipolar disorder. BIPOLAR DISORDERS, 5(1), 48-52.

The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders.
Rapkin, A. J., Mikacich, J. A., Moatakef-Imani, B., & Rasgon, N. (2002). The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Current psychiatry reports, 4(6), 419-428.

Mood symptoms and cognitive performance in women estrogen users and nonusers and men
Miller, K. J., Conney, J. C., Rasgon, N. L., Fairbanks, L. A., & Small, G. W. (2002). Mood symptoms and cognitive performance in women estrogen users and nonusers and men. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 50(11), 1826-1830.

Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review.
Rasgon, N. L., Carter, M. S., Elman, S., Bauer, M., Love, M., & KORENMAN, S. G. (2002). Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review. Current drug targets. Immune, endocrine and metabolic disorders, 2(1), 97-102.

Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women
Rasgon, N. L., Altshuler, L. L., Fairbanks, L. A., Dunkin, J. J., Davtyan, C., & Rapkin, A. J. (2002). Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. JOURNAL OF CLINICAL PSYCHIATRY, 63, 45-48.

Estrogen-replacement therapy for depression
Rasgon, N. L., Altshuler, L. L., & Fairbanks, L. (2001). Estrogen-replacement therapy for depression. AMERICAN JOURNAL OF PSYCHIATRY, 158(10), 1738-1738.

Affective disorders and Alzheimer disease: A missing-link hypothesis
Rasgon, N., Jarvik, G. P., & Jarvik, L. (2001). Affective disorders and Alzheimer disease: A missing-link hypothesis. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 9(4), 444-445.

Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome
Rasgon, N., Serra, M., Biggio, G., Pisu, M. G., Fairbanks, L., & Rapkin, A. (2001). Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 145(1), 25-33.

Estrogen use and brain metabolic change in older adults. A preliminary report
Rasgon, N. L., Small, G. W., Siddarth, P., Miller, K., Ercoli, L. M., & Phelps, M. E. (2001). Estrogen use and brain metabolic change in older adults. A preliminary report. PSYCHIATRY RESEARCH-NEUROIMAGING, 107(1), 11-18.

Menstrual cycle-related brain metabolite changes using H-1 magnetic resonance spectroscopy in premenopausal women: a pilot study
Rasgon, N. L., Thomas, M. A., Guze, B. H., Fairbanks, L. A., Yue, K., & Rapkin, A. J. (2001). Menstrual cycle-related brain metabolite changes using H-1 magnetic resonance spectroscopy in premenopausal women: a pilot study. PSYCHIATRY RESEARCH-NEUROIMAGING, 106(1), 47-57.

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
Small, G. W., Ercoli, L. M., Silverman, D. Hs., Huang, S. C., Komo, S., & Phelps, M. E. (2000). Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 97(11), 6037-6042.

Medication status and polycystic ovary syndrome in women with bipolar disorder: A preliminary report
Rasgon, N. L., Altshuler, L. L., Gudeman, D., Burt, V. K., Tanavoli, S., & Korenman, S. (2000). Medication status and polycystic ovary syndrome in women with bipolar disorder: A preliminary report. JOURNAL OF CLINICAL PSYCHIATRY, 61(3), 173-178.

Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder
Suri, R. A., Altshuler, L. L., Rasgon, N. L., Calcagno, J. L., Frye, M. A., & Zuckerbrow-Miller, J. (2000). Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder. JOURNAL OF CLINICAL PSYCHIATRY, 61(12), 942-946.

Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome
Rasgon, N., McGuire, M., Tanavoli, S., Fairbanks, L., & Rapkin, A. (2000). Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome. FERTILITY AND STERILITY, 73(1), 144-149.

Toward optimal health: the experts respond to depression. Interview by Jodi Godfrey Meisler.
Rasgon, N., & Nonacs, R. (1999). Toward optimal health: the experts respond to depression. Interview by Jodi Godfrey Meisler. Journal of women's health & gender-based medicine, 8(9), 1141-1146.

Depressive symptoms in the perimenopause: Prevalence, assessment, and guidelines for treatment
Burt, V. K., Altshuler, L. L., & Rasgon, N. (1998). Depressive symptoms in the perimenopause: Prevalence, assessment, and guidelines for treatment. HARVARD REVIEW OF PSYCHIATRY, 6(3), 121-132.

AGENESIS OF CORPUS-CALLOSUM AND DEMENTIA OF THE ALZHEIMERS TYPE - A REVIEW AND CASE-REPORT
Rasgon, N., Ananth, J., MENA, I., KROUT, B., & Boone, K. (1994). AGENESIS OF CORPUS-CALLOSUM AND DEMENTIA OF THE ALZHEIMERS TYPE - A REVIEW AND CASE-REPORT. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 39(7), 429-432.

[Alpha-tocopherol induced activation of the endogenous opioid system].
Kryzhanovskii, G. N., LUZINA, N. L., & IARYGIN, K. N. (1989). [Alpha-tocopherol induced activation of the endogenous opioid system]. Biulleten' eksperimental'noi biologii i meditsiny, 108(11), 566-567.

[The inhibition stage of lipid peroxidation during stress].
Guliaeva, N. V., LUZINA, N. L., Levshina, I. P., & Kryzhanovskii, G. N. (1988). [The inhibition stage of lipid peroxidation during stress]. Biulleten' eksperimental'noi biologii i meditsiny, 106(12), 660-663.

[Endogenous opioid system in the realization of the analgesic effect of alpha-tocopherol in reference to algomenorrhea].
Kryzhanovskii, G. N., BAKULEVA, L. P., LUZINA, N. L., Vinogradov, V. A., & IARYGIN, K. N. (1988). [Endogenous opioid system in the realization of the analgesic effect of alpha-tocopherol in reference to algomenorrhea]. Biulleten' eksperimental'noi biologii i meditsiny, 105(2), 148-150.

[Use of an antioxidant, alpha-tocopherol acetate, in the complex treatment of algomenorrhea].
LUZINA, N. L., & Vakuleva, L. P. (1987). [Use of an antioxidant, alpha-tocopherol acetate, in the complex treatment of algomenorrhea]. Akusherstvo i ginekologii?a, (5), 67-69.

[Body reactivity characteristics of chronic salpingo-oophoritis patients at the health resort stage of rehabilitation].
LUZINA, N. L., Zelinskii, A. A., & Kryzhanovskii, G. N. (1986). [Body reactivity characteristics of chronic salpingo-oophoritis patients at the health resort stage of rehabilitation]. Akusherstvo i ginekologii?a, (11), 69-71.